Top Healthcare stocks in Australia
Manufacturers, developers and marketers of pharmaceuticals, medical equipment and supplies, as well as advanced therapeutic treatments and devices, and providers of healthcare facilities and medical research and development.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
CSLCSL | AU$142.78bn | 37.67 | 1.29% |
COHCochlear | AU$20.81bn | 57.39 | 0.55% |
PMEPro Medicus | AU$14.03bn | 201.17 | 0.26% |
SHLSonic Healthcare | AU$12.28bn | 24.16 | 4.07% |
RHCRamsay Health Care | AU$10.61bn | 158.76 | 1.4% |
TLXTelix Pharmaceuticals | AU$5.83bn | 1016.37 | n/a |
ANNAnsell | AU$3.18bn | 14.45 | 2.55% |
NEUNeuren Pharmaceuticals | AU$2.54bn | 16.17 | n/a |
SIGSigma Healthcare | AU$2.04bn | 306.6 | 0.76% |
PNVPolynovo | AU$1.61bn | 1438.27 | n/a |
CU6Clarity Pharmaceuticals | AU$1.39bn | n/a | n/a |
REGRegis Healthcare | AU$1.27bn | n/a | 3.27% |
MSBMesoblast | AU$1.14bn | n/a | n/a |
HLSHealius | AU$1.05bn | n/a | n/a |
NANNanosonics | AU$902.43m | 58.28 | n/a |
EHEEstia Health | AU$795.75m | n/a | 5.1% |
CUVClinuvel Pharmaceuticals | AU$777.47m | 25.73 | 0.32% |
IDXIntegral Diagnostics | AU$604.57m | n/a | 2.32% |
BOTBotanix Pharmaceuticals | AU$526.03m | n/a | n/a |
ACLAustralian Clinical Labs | AU$507.27m | 27.24 | 3.95% |